NCT03704740 Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months Status COMPLETED Phase PHASE3
NCT03699839 Reducing the Burden of Influenza After Solid-Organ Transplantation Status COMPLETED Phase PHASE2/PHASE3
NCT03698279 Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age Status COMPLETED Phase PHASE2
NCT03694392 Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years Status COMPLETED Phase N/A
NCT03686514 The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics Status TERMINATED Phase PHASE4
NCT03684044 Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza Status COMPLETED Phase PHASE3
NCT03679143 The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT03669627 CT18 Infant Influenza Priming Study in Vaccine Naive Infants Status COMPLETED Phase PHASE2
NCT03653364 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms Status COMPLETED Phase PHASE3
NCT03629184 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms Status COMPLETED Phase PHASE3
NCT03617523 Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations Status COMPLETED Phase PHASE4
NCT03603509 Gene Signatures of Influenza Vaccine Responses in Older Adults Status COMPLETED Phase PHASE4
NCT03595358 Ellume·Lab Flu A+B Test and the Ellume Home Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction Status COMPLETED Phase NA
NCT03594890 Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03590808 Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor Status COMPLETED Phase NA